The new biotechnological and pharmaceutical plant in the northeastern Bulgarian town of Razgrad will create jobs for highly skilled and highly paid specialists, Kiril Domuschiev, the chairman of the Biovet AD Supervisory Board and executive director of Huvepharma AD, which is the main shareholder in Biovet AD, says in an interview with FOCUS News Agency.
The planned investment is worth EUR 25 million for 12 months. He says the plant will offer jobs for chemists, biologists, pharmacists, engineers, as well as IT specialists because it will be highly automated
The planned investment is worth EUR 25 million for 12 months. He says the plant will offer jobs for chemists, biologists, pharmacists, engineers, as well as IT specialists because it will be highly automated
No comments:
Post a Comment